Mutated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressing Leukemia Cells.
Technology
E-129-2001
Patent ID
E-129-2001-0-CA-06
Country
CA
Application Type
National Stage
Patent Status
Expired
Patent Number
Publication Number
Application Number
2461351
IC
NCI
Date Filed
Date Issued
Patent PDF